Target intelligence / Profile preview

Novel transcript, antisense to MTA3 (LOC105374555)

Target
LOC105374555
Molecular classification
Other (natural antisense RNA, putative long non-coding RNA)
01

Overview

Novel transcript, antisense to MTA3 (ENSG00000303185, LOC105374555), refers to a long non-coding RNA annotated in the human genome, transcribed from the strand opposite to the MTA3 gene. Its function is not experimentally characterized, but by analogy to other natural antisense transcripts, it could potentially regulate the expression or processing of the overlapping MTA3 gene[1][2][3]. Antisense RNAs can influence sense gene transcripts by mechanisms such as affecting transcript stability, processing, and chromatin environment, yet there is no evidence that this specific transcript is a receptor, enzyme, transporter, or therapeutic target, nor is it directly implicated in any disease process or drug pathway[1][2][3]. Novel transcript, antisense to MTA3" (ENSG00000303185, LOC105374555) is a bioinformatically-predicted or experimentally observed non-coding RNA antisense to the MTA3 gene. It is not a receptor, enzyme, transporter, or therapeutic target, and there is no evidence of drug interactions, biomarker utility, or disease linkage specific to this transcript[1][2][3].

Other names
ENSG00000303185LOC105374555novel transcript antisense to MTA3
02

Mechanism of action

N/A

03

Biological functions

Gene regulation via antisense RNA mechanisms (postulated)Regulation of chromatin state (inferred from role of antisense transcripts[1][2][3])Modulation of sense transcript stability and expression (general property of antisense RNAs[1][2][3])
04

Disease associations

Other (unknown for this specific transcript; general antisense effects can be involved in disease regulation, but no established link for this transcript)

Beyond the preview

Go deeper on Novel transcript, antisense to MTA3 (LOC105374555).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel transcript, antisense to MTA3 (LOC105374555).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call